Physician profile
David E Reinhardt
NPI 1548255169
$18,343.70
in general payments reported to CMS, 2019-2025
17 companies · $899 in 2025
The $899 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $183 · 2021: $106 · 2022: $598 · 2023: $269 · 2024: $4,716 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,212 · Food and Beverage: $2,516 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,211.68 |
| Food and Beverage | $2,516.06 |
| Education | $156.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $11,581.51 | 2019-2023 | Primary Shoulder, Gmk Sphere, Myknee |
| Smith+Nephew, INC. | $3,784.90 | 2022-2025 | Journey II, Legion Revision, Journey |
| Arthrex, INC. | $973.70 | 2024 | |
| Paladin Technology Solutions | $715.39 | 2023-2024 | |
| Stryker Corporation | $475.97 | 2020-2025 | Pangea, Gamma |
| Fidia Pharma USA INC. | $280.44 | 2019-2025 | Hymovis, Richplat Ortho Prp System, Triluron |
| Zimmer Biomet Holdings, INC. | $150.20 | 2019-2025 | Gel-One Cross-Linked Hyaluronate |
| Catalyst Orthoscience | $73.87 | 2025 | |
| Heraeus Medical, LLC. | $57.15 | 2019-2025 | |
| Liberty Surgical INC. | $54.25 | 2021 | |
| Pacira Therapeutics, INC. | $44.75 | 2019 | |
| Heron Therapeutics, INC. | $36.30 | 2021-2022 | |
| Nalu Medical, INC. | $35.33 | 2025 | Nalu Neurostimulation System |
| Treace Medical Concepts, INC. | $25.80 | 2025 | |
| Solventum Corporation | $23.86 | 2025 | Prevena |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $18.17 | 2024 | Monovisc |
| Horizon Therapeutics Plc | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Reinhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.